Reed Technology Awarded FDA Contract for Prescription Drug Labeling Improvement and Enhancement Initiative (PDLI-EI)

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HORSHAM, Pa.--(BUSINESS WIRE)--Reed Technology and Information Services Inc. (Reed Tech), part of the LexisNexis® family, is pleased to announce it has been awarded a contract with the U.S. Food and Drug Administration (FDA) to convert prescription drug labeling from its current format to the Physician Labeling Rule (PLR) format. The purpose of this contract is to provide FDA’s Center for Drug Evaluation (CDER) with the necessary services to complete a number of projects planned over five years aimed at improving and enhancing prescription drug labeling. The estimated contract value is $26 million over the five year period.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC